BR0107157A - Diagnose e tratamento de condições cardiovasculares - Google Patents
Diagnose e tratamento de condições cardiovascularesInfo
- Publication number
- BR0107157A BR0107157A BR0107157-2A BR0107157A BR0107157A BR 0107157 A BR0107157 A BR 0107157A BR 0107157 A BR0107157 A BR 0107157A BR 0107157 A BR0107157 A BR 0107157A
- Authority
- BR
- Brazil
- Prior art keywords
- diagnosis
- treatment
- cardiovascular conditions
- relates
- cardiovascular
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Cell Biology (AREA)
- Hospice & Palliative Care (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
"DIAGNOSE E TRATAMENTO DE CONDIçõES CARDIOVASCULARES". A presente invenção refere-se a métodos e composições para a diagnose e tratamento de condições cardiovasculares. Mais especificamente, a invenção refere-se ao diagnóstico e terapêutica envolvendo moléculas isoladas que podem ser usadas para impedir a morte da célula apoptótica cardíaca.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US22715900P | 2000-08-22 | 2000-08-22 | |
PCT/US2001/026089 WO2002016416A2 (en) | 2000-08-22 | 2001-08-21 | Diagnosis and treatment of cardiovascular conditions |
Publications (1)
Publication Number | Publication Date |
---|---|
BR0107157A true BR0107157A (pt) | 2002-07-16 |
Family
ID=22852000
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR0107157-2A BR0107157A (pt) | 2000-08-22 | 2001-08-21 | Diagnose e tratamento de condições cardiovasculares |
Country Status (9)
Country | Link |
---|---|
US (1) | US20020115081A1 (pt) |
EP (1) | EP1311547A2 (pt) |
JP (1) | JP2004506443A (pt) |
AU (1) | AU8513901A (pt) |
BR (1) | BR0107157A (pt) |
CA (1) | CA2388061A1 (pt) |
IL (1) | IL149251A0 (pt) |
RU (1) | RU2002110275A (pt) |
WO (1) | WO2002016416A2 (pt) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20090176722A9 (en) | 2000-01-28 | 2009-07-09 | Shiv Srivastava | Androgen-regulated PMEPA1 gene and polypeptides |
US6640135B1 (en) * | 2000-04-06 | 2003-10-28 | Cardiac Pacemakers, Inc. | Apparatus and method for spatially and temporally distributing cardiac electrical stimulation |
AU2001275339A1 (en) | 2000-06-05 | 2001-12-17 | The Trustees Of Columbia University In The City Of New York | Identification and use of human bone marrow-derived endothelial progenitor cells to improve myocardial function after ischemic injury |
US7432060B2 (en) | 2000-11-09 | 2008-10-07 | The Brigham And Women's Hospital, Inc. | Methods for diagnosis of cardiovascular disease |
US6628988B2 (en) * | 2001-04-27 | 2003-09-30 | Cardiac Pacemakers, Inc. | Apparatus and method for reversal of myocardial remodeling with electrical stimulation |
US6973349B2 (en) * | 2001-12-05 | 2005-12-06 | Cardiac Pacemakers, Inc. | Method and apparatus for minimizing post-infarct ventricular remodeling |
US6915160B2 (en) * | 2002-02-08 | 2005-07-05 | Cardiac Pacemakers, Inc. | Dynamically optimized multisite cardiac resynchronization device |
US20030199464A1 (en) * | 2002-04-23 | 2003-10-23 | Silviu Itescu | Regeneration of endogenous myocardial tissue by induction of neovascularization |
HUE039881T2 (hu) | 2002-05-09 | 2019-02-28 | Brigham & Womens Hospital Inc | 1L1RL-1, mint egy kardiovaszkuláris betegség-marker |
US6965797B2 (en) * | 2002-09-13 | 2005-11-15 | Cardiac Pacemakers, Inc. | Method and apparatus for assessing and treating myocardial wall stress |
US20040186155A1 (en) * | 2003-01-30 | 2004-09-23 | Dayno Jeffrey Marc | Combination therapy for the treatment or prevention of migraine |
JP4925033B2 (ja) * | 2004-02-03 | 2012-04-25 | 学校法人 久留米大学 | ストレス誘導抗アポトーシス分子(iex−1)由来ペプチド |
WO2006078853A2 (en) | 2005-01-20 | 2006-07-27 | University Of Rochester | Thioredoxin interacting protein (txnip) as regulator of vascular function |
US9050393B2 (en) * | 2005-02-08 | 2015-06-09 | Bruce N. Saffran | Medical devices and methods for modulation of physiology using device-based surface chemistry |
US7366567B2 (en) | 2005-03-23 | 2008-04-29 | Cardiac Pacemakers, Inc. | Method for treating myocardial infarction |
ES2351623T3 (es) | 2006-04-24 | 2011-02-08 | Critical Care Diagnostics, Inc. | Predicción de la mortalidad y detección de una enfermedad grave. |
JP5377289B2 (ja) | 2006-05-01 | 2013-12-25 | クリティカル ケア ダイアグノスティクス インコーポレイテッド | 心血管疾患の診断方法 |
US8147817B2 (en) * | 2006-05-04 | 2012-04-03 | The Brigham And Women's Hospital, Inc. | IL-33 in the treatment and diagnosis of diseases and disorders |
PT2269063E (pt) | 2008-04-18 | 2013-11-27 | Critical Care Diagnostics Inc | Predição do risco de eventos cardíacos adversos maiores |
US8728742B2 (en) | 2011-03-17 | 2014-05-20 | Critical Care Diagnostics, Inc. | Methods predicting risk of an adverse clinical outcome |
WO2013134632A2 (en) * | 2012-03-09 | 2013-09-12 | Fibrogen, Inc. | Treatment for high cholesterol |
CA2882303A1 (en) | 2012-08-21 | 2014-02-27 | Critical Care Diagnostics, Inc. | Multimarker risk stratification |
NZ705899A (en) * | 2012-09-07 | 2018-08-31 | Inst Nat Sante Rech Med | Inhibiting peptides derived from triggering receptor expressed on myeloid cells-1 (trem-1) trem-like transcript 1 (tlt-1) and uses thereof |
US9265458B2 (en) | 2012-12-04 | 2016-02-23 | Sync-Think, Inc. | Application of smooth pursuit cognitive testing paradigms to clinical drug development |
MD707Z (ro) * | 2013-01-18 | 2014-07-31 | Институт Зоологии Академии Наук Молдовы | Metodă de identificare a secvenţelor polimorfe 4a/4b ale genei sintetazei endoteliale a oxidului nitric |
US9380976B2 (en) | 2013-03-11 | 2016-07-05 | Sync-Think, Inc. | Optical neuroinformatics |
FR3100714A1 (fr) * | 2019-09-12 | 2021-03-19 | L'Air Liquide, Société Anonyme pour l'Etude et l'Exploitation des Procédés Georges Claude | Argon associé à une thrombectomie en cas d’accident vasculaire cérébral ischémique |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5217899A (en) * | 1990-08-24 | 1993-06-08 | The General Hospital Corporation | Cell stretching apparatus |
JP2002524049A (ja) * | 1998-08-07 | 2002-08-06 | オニックス ファーマシューティカルズ,インコーポレイティド | Chpポリペプチド、pak65のリガンド |
WO2000034477A2 (en) * | 1998-12-11 | 2000-06-15 | Incyte Pharmaceuticals, Inc. | Neuron-associated proteins |
JP2002539773A (ja) * | 1999-03-01 | 2002-11-26 | ミレニウム ファーマシューティカルズ,インコーポレーテッド | 分泌タンパク質およびそれらをコードする核酸 |
US20030180728A1 (en) * | 2002-03-22 | 2003-09-25 | Kovacs Karl F. | Human BCU399 gene, polypeptide, and uses |
-
2001
- 2001-08-21 EP EP01964262A patent/EP1311547A2/en not_active Withdrawn
- 2001-08-21 IL IL14925101A patent/IL149251A0/xx unknown
- 2001-08-21 US US09/934,249 patent/US20020115081A1/en not_active Abandoned
- 2001-08-21 JP JP2002521511A patent/JP2004506443A/ja active Pending
- 2001-08-21 RU RU2002110275/13A patent/RU2002110275A/ru not_active Application Discontinuation
- 2001-08-21 AU AU85139/01A patent/AU8513901A/en not_active Abandoned
- 2001-08-21 WO PCT/US2001/026089 patent/WO2002016416A2/en active Application Filing
- 2001-08-21 BR BR0107157-2A patent/BR0107157A/pt not_active Application Discontinuation
- 2001-08-21 CA CA002388061A patent/CA2388061A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2002016416A2 (en) | 2002-02-28 |
CA2388061A1 (en) | 2002-02-28 |
RU2002110275A (ru) | 2004-03-27 |
EP1311547A2 (en) | 2003-05-21 |
WO2002016416A3 (en) | 2003-03-13 |
AU8513901A (en) | 2002-03-04 |
US20020115081A1 (en) | 2002-08-22 |
JP2004506443A (ja) | 2004-03-04 |
IL149251A0 (en) | 2002-11-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR0107157A (pt) | Diagnose e tratamento de condições cardiovasculares | |
BR9913288A (pt) | Composição antioxidante compreendendo acetil l-carnitina e ácido alfa-lipóico | |
CA2224528A1 (fr) | Composes stilbeniques a groupement adamantyl, compositions les contenant et utilisations | |
BR9914044A (pt) | ésteres tetrahidropirido | |
BR0313630A (pt) | Composição para aplicação tópica, sistema para o tratamento de caspa, métodos para o tratamento e/ou prevenção da caspa e da coceira do couro cabeludo e usos de uma combinação sinérgica | |
CA2191789A1 (fr) | Composes biaromatiques portant un groupement adamantyl en ortho, compositions pharmaceutiques et cosmetiques les contenant et utilisations de ces compositions | |
CA2238465A1 (fr) | Composes triaromatiques, compositions les contenant et utilisations | |
BR0116945A (pt) | Uma preparação para prevenção de restenose | |
TNSN01125A1 (fr) | Compositions pharmaceutiques comprenant un inhibiteur de cetp et de l'atorvastatine | |
HUP0303665A2 (hu) | Káliumcsatorna-blokkoló hatású arilezett furán- és tiofén-karbonsavamidok | |
BR9813811A (pt) | "composições farmacêuticas compreendendo micelas que compreendem glicocorticosteróide lipofìlico e apenas um único tensoativo" | |
BR0103256A (pt) | Utilização de substâncias bioquìmicas para uma composição para a prevenção e tratamento de condições de saúde causadas por constrição de células de músculo liso em órgãos do corpo humano | |
BR0318278A (pt) | compostos de éter aminocicloexìlico e usos dos mesmo | |
CA2218766A1 (fr) | Composes bicycliques-aromatiques | |
TR200003736T2 (tr) | Anksiyete durumlarına ya da depresyona bağlı değişikliklerin önlenmesi | |
BR0312845A (pt) | Tetratiomolibdato de tetrapropilamÈnio e compostos relacionados para terapias antiangiogênicas | |
CA2191790A1 (fr) | Composes biaromatiques portant un groupement adamantyl en para, compositions pharmaceutiques et cosmetiques les contenant et utilisations de ces compositions | |
CA2264979A1 (fr) | Composes bicycliques-aromatiques et leur utilisation en medecine humaine ou veterinaire ainsi qu'en cosmetologie | |
BRPI0415753A (pt) | método para tratamento e prevenção da inflamação respiratória com um inibidor de ciclooxigenase-2 em associação com um inibidor de fosfodiesterase 4 e composições que os contêm | |
NO20016004D0 (no) | Sammensetning som innbefatter alkalin-sfingomyelinase for anvendelse som et kostholdspreparat, n¶ringsmiddeltilskudd ellerfarmasöytisk produkt | |
PT942741E (pt) | Composicoes de lectina e suas utilizacoes | |
MX9501849A (es) | Nuevos compuestos biciclicos-aromaticos, composiciones farmaceuticas y cosmeticas que los contienen y sus usos. | |
DK1035859T3 (da) | Anvendelse af phospholipidkomplekser fra ekstrakter af Vitis vinifera som anti-atherosklerotiske midler | |
BR0313413A (pt) | Uso da vacinação beta amilóide juntamente com um inibidor da cox-2 seletivo para o tratamento da doença de alzheimer | |
CA2305933A1 (fr) | Composes (poly)thia-alcynoiques et leurs derives, compositions les comprenant et leur utilisation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B11A | Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing | ||
B11Y | Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette] |